Medical Pharmacology:
Anti-Psychotic Drug Practice Questions
Click on the correct answer.
Which one(s) ) of the following agents is/are approved both for management of acute mania and for recurrence prevention?
- Valproic acid
- Carbamazepine
- Lamotrigine
- A & B
- A & C
- B & C
- A, B & C
Lamotrigine has been approved for preventing recurrence of acute mania.
- True
- False
Approved for managing bipolar depression:
- Quetiapine
- Olanzapine + fluoxetine
- Both
- Neither
Occasionally used in managing bipolar disorder yet not approved by the FDA for this clinical indication:
- Topiramate
- Oxcarbazepine
- Gabapentin
- A & B
- B & C
- A, B & C
Lithium's therapeutic mechanism of action and treating bipolar disorder may be due to its action on phosphoinositol turnover.
- True
- False
Lithium remains the drug of choice for treatment of bipolar disorder, particularly focusing on the manic phase.
- True
- False
This/these agent(s) may be used as a component of treating the depressive phase of bipolar disorder:
- Lurasidone
- Quetiapine
- Both
- Neither
Salvage treatment for schizophrenia management may involve adding this/these agent(s) to an antipsychotic regimen:
- Lithium
- Carbamazepine
- Both
- Neither
Lithium-ion is relatively poorly absorbed following oral administration.
- True
- False
Primary route of administration for lithium:
- By hepatic biotransformation
- Through the pulmonary system
- By renal excretion in the urine
If you wish to return to the Table of Contents
in ENGLISH, press the RETURN button above. |
Otherwise, if the text is NOT displayed in
English and you are ready to leave this page,
Press here
to return to the Table of Contents
|